Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: J Urol. 2016 Sep 14;197(3 Pt 1):632–639. doi: 10.1016/j.juro.2016.09.070

Table 5.

Kaplan-Meier survivor functions by GS and PSAD (ng/ml/cm3).

Group Time (months) Number at Risk (n) Survivor Function 95% CI
0 161 1.00 ± 0 0.00
GS 3+3 12 107 0.97 ± 0.02 0.92–0.99
PSAD < 0.15 24 59 0.93 ± 0.02 0.86–0.97
36 21 0.85 ± 0.05 0.71–0.93

0 35 1.00 ± 0 0.00
GS 3+3 12 21 0.92 ± 0.05 0.73–0.98
PSAD ≥ 0.15 24 7 0.73 ± 0.11 0.43–0.89
36 3 0.73 ± 0.11 0.43–0.89

0 39 1.00 ± 0 0.00
GS 3+4 12 20 0.88 ± 0.06 0.72–0.95
PSAD < 0.15 24 8 0.77 ± 0.11 0.45–0.92
36 7 0.66 ± 0.14 0.32–0.86

0 24 1.00 ± 0 0.00
GS 3+4 12 8 0.59 ± 0.13 0.31–0.79
PSAD ≥ 0.15 24 1 0.39 ± 0.18 0.09–0.70